Op18/stathmin mediates multiple region-specific tubulin and microtubule-regulating activities.
Oncoprotein18/stathmin (Op18) is a regulator of microtubule (MT) dynamics that binds tubulin heterodimers and destabilizes MTs by promoting catastrophes (i.e., transitions from growing to shrinking MTs). Here, we have performed a deletion analysis to mechanistically dissect Op18 with respect to (a) modulation of tubulin GTP hydrolysis and exchange, (b) tubulin binding in vitro, and (c) tubulin association and MT-regulating activities in intact cells. The data reveal distinct types of region-specific Op18 modulation of tubulin GTP metabolism, namely inhibition of nucleotide exchange and stimulation or inhibition of GTP hydrolysis. These regulatory activities are mediated via two-site cooperative binding to tubulin by multiple nonessential physically separated regions of Op18. In vitro analysis revealed that NH(2)- and COOH-terminal truncations of Op18 have opposite effects on the rates of tubulin GTP hydrolysis. Transfection of human leukemia cells with these two types of mutants result in similar decrease of MT content, which in both cases appeared independent of a simple tubulin sequestering mechanism. However, the NH(2)- and COOH-terminal-truncated Op18 mutants regulate MTs by distinct mechanisms as evidenced by morphological analysis of microinjected newt lung cells. Hence, mutant analysis shows that Op18 has the potential to regulate tubulin/MTs by more than one specific mechanism.
Larsson
N
N
Department of Cell and Molecular Biology, University of Umeâ, Sweden.
Segerman
B
B
Howell
B
B
Fridell
K
K
Cassimeris
L
L
Gullberg
M
M
D000495:Allosteric Site; D000818:Animals; D002478:Cells, Cultured; D019281:Dimerization; D020558:GTP Phosphohydrolases / Q000378:metabolism; D006160:Guanosine Triphosphate / Q000378:metabolism; D006801:Humans; D006868:Hydrolysis / Q000187:drug effects; D020014:K562 Cells; D007700:Kinetics; D008868:Microtubule Proteins; D008870:Microtubules / Q000187:drug effects / Q000378:metabolism*; D015739:Nocodazole / Q000494:pharmacology; D010641:Phenotype; D010750:Phosphoproteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D011108:Polymers; D011485:Protein Binding; D011993:Recombinant Fusion Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D012455:Salamandridae; D017384:Sequence Deletion; D050777:Stathmin; D014404:Tubulin / Q000378:metabolism*
D008868:Microtubule Proteins; D010750:Phosphoproteins; D011108:Polymers; D011993:Recombinant Fusion Proteins; C493995:STMN1 protein, human; D050777:Stathmin; D014404:Tubulin; D006160:Guanosine Triphosphate; D020558:GTP Phosphohydrolases; D015739:Nocodazole